Why is Transgene Biotek falling/rising?

As of 12-Sep, Transgene Biotek Ltd is currently priced at 3.81, reflecting a slight increase of 0.03 or 0.79%. Despite this uptick today, the stock has shown a significant decline over the past week, down 3.79%, and a more considerable drop of 20.46% over the past month. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, investor participation has decreased, with delivery volume falling by 41.13% compared to the 5-day average, suggesting reduced interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, Transgene Biotek's performance has been notably weaker compared to the benchmark, the Sensex, which has gained 1.48% over the past week. This stark contrast highlights the stock's underperformance, particularly as it has declined by 44.22% year-to-date while the Sensex has increased by 4.82%. The overall market sentiment appears to favor the benchmark, further exacerbating the challenges faced by Transgene Biotek in attracting investor confidence and participation.